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Background: Oxytocin is a stress-attenuating and pro-social neuropeptide. To date, no study 
has looked at the effects of oxytocin in modulating brain activity in depressed individuals nor 
attempted to correlate this activity with attribution of mental activity in others. Method: We 
enrolled 10 unmedicated depressed adults and 10 matched healthy controls in a crossover, 
double blind placebo controlled fMRI 40 i.u. intra-nasal oxytocin study (20 i.u. per nostril). Each 
subject performed reading the mind in the eyes task (RMET) before and after inhalation of 
oxytocin or placebo control for a total of 80 scans. Results: Before oxytocin administration, 
RMET engaged the medial and lateral prefrontal cortex, amygdala, insula and associative 
areas. Depressed subjects showed increased anterior ventral activation for the RMET minus 
gender identification contrast whereas matched controls showed increased dorsal and frontal 
activity. Compared to placebo, oxytocin in depressed subjects showed increased activity in the 
superior middle frontal gyrus and insula, while controls exhibited more activity in ventral regions. 
Oxytocin also led to inverse effects in reaction times on attribution task between groups, with 
controls getting faster and depressed individuals slower to respond. Conclusion: Depression 
is associated with increased paralimbic activity during emotional mental attribution of others, 
appearing to be distinctly modulated by oxytocin when compared to healthy controls. Further 
studies are needed to explore long-term exposure to pro-social neuropeptides on mood in 
depressed populations and assess their clinical relevance.
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It is increasingly released in affectively rich dyadic settings such 
a when social attunement occurs between mother and infant, in 
breastfeeding, early skin to skin contact, and later in sexual inter-
course and climax (Nelson and Panksepp, 1998; Uvnas-Moberg, 
1998). Conversely, low levels of oxytocin have been linked to depres-
sion (Bell, 2006), with patients experiencing and observed to possess 
“dis-affiliation” with others. Also, critical social events marked with 
insecure attachment or losses of significant others often precipitate 
depressive symptoms (Anisman, 1984). Functional neuroimaging 
studies consistently find abnormal ventral limbic and paralimbic 
activity in depression (Price and Drevets, 2009) – the very same 
regions implicated in the mediation of social relatedness and men-
talization (Choi-Kain and Gunderson, 2008; Hartmann, 2009).
Theory of mind (ToM) is a research and conceptual rubric of an 
“imagined involvement” that was derived from studies of autism. 
Mentalization is a higher order capacity, either deficient in clinical 
populations or progressively enhanced with better caretaking and 
affective attunement. The failure to evolve mentalization partially 
IntroductIon
Mentalization, a developmentally derived ability to affectively and 
cognitively infer the mental state of others is crucial to sociality and 
is enhanced by propitious genetics and secure attachments (Choi-
Kain and Gunderson, 2008; Hartmann, 2009). Mentalization allows 
individuals to estimate others’ states of mind, and one’s reactions 
and reflections upon that approximation represent an advantageous 
ability given that humans need good social bonds for maximum 
health, adaptation, and richer relationships. It begins in infancy 
and is facilitated by positive social interactions (Fonagy and Target, 
2007) and early attachment experiences (Meins et al., 2002).
Although little is known about the neurophysiology of such expe-
riences, there is evidence that oxytocin, a neuropeptide, promotes 
positive social interactions and preferences (Hurlemann et al., 2010, 
Winslow and Insel, 2004; Zak et al., 2005), enhances socially rein-
forced learning and faces recognition (Marsh et al., 2010, Guastella 
et al., 2008), exerts anxiolytic effects and is a key modulator of early 
mother-infant bonding and maternal caretaking (Panksepp, 2005). Frontiers in Psychiatry  |  Neuropsychiatric Imaging and Stimulation    October 2010  | Volume 1  | Article 134  |  2
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  depressive   episode by Structured Clinical Interview for DSM-IV 
Axis I Disorders (SCID-I) criteria of less than 24 months in dura-
tion with an antidepressant treatment history form (ATHF) sever-
ity one or less failed trials. Healthy controls were screened for any 
active DSM-IV-TR Axis I diagnosis (with the exception of caffeine 
or nicotine abuse). Subjects were off all psychotropic medications 
for at least 2 weeks prior to first scanning session. Subjects were 
excluded if they were medically unstable or had an active neurode-
generative or epilepsy disorder. All presented data are from subjects 
who completed a baseline clinical assessment visit along with two 
scanning sessions over a maximum of 3 weeks period.
ScannIng and drug InhalatIon procedureS
At each scanning session, subjects underwent two identical blood oxy-
gentation dependant (BOLD) fMRI scans before and approximately 
10 min after inhalation of study drug (20 IU oxytocin or placebo per 
nostril; Lee-Silsby Pharmacy, Cleveland, OH, USA). The oxytocin dose 
is comparable to that used previously in human studies of behavior 
(Epperson et al., 1996a,b; Ditzen et al., 2007). Randomization and 
subject’s assignment were performed by MUSC Investigational Drug 
Services and the McClellan Banks Pharmacy. Data was unmasked after 
study completion and all data were locked. Subjects abstained from 
alcohol and nicotine for 12 h before the experiment.
readIng the MInd In the eyeS paradIgM
We adapted the reading the mind in the eyes paradigm (RMET) for 
presentation in the scanner and an event-fMRI design. We used the 
Integrated Functional Imaging System (IFIS-SA) (Invivo, Orlando, 
FL, USA) to visually present the paradigm and record responses 
of the participants. The RMET task consisted of three conditions: 
affect attribution of faces cropped around the eyes in rectangu-
lar shape (referred in the text as RMET), gender identification of 
the same photographs, and a basic motor cued response. Possible 
attribute adjectives, gender attributes (“male,” “female”) and motor 
cues (“yes,” “no”) were positioned at the four corners with opti-
mal or normed responses equally randomized for all presentations. 
Participants pressed a hand-pad button to indicate their attribute 
of choice. On the hand-pad, the left and right index fingers cor-
responded to the top left and top right corners of images, and the 
left and right thumbs corresponded to the bottom left and bottom 
right corners of images. This entire paradigm consisted of 32 events 
for each condition (96 events total presented in a fixed-randomized 
order) and lasted approximately 769 s. The duration of each event 
lasted 7 s, separated by a jittered inter-stimulus black screen [inter-
stimulus interval (ISI) range 6–4753 ms, ISI average = 1008 ms].
IMage acquISItIon
Images were acquired using a 3T MRI scanner (Intera, Philips Medical 
System, Netherlands) with a SENSE parallel imaging head-coil. A 
sagittal reference image was first acquired, to guide positioning of 
the functional scans along the anterior commissure-posterior com-
missure line. For scanning during the RMET paradigm, echoplanar 
(EPI) transverse images were acquired with the following param-
eters: 414 volumes, repetition time = 1867 ms, echo time = 30 ms, 
flip angle = 90°, field of view = 208 mm, matrix = 64 × 64, SENSE 
factor = 2, 32 slices, 3.25 mm with no gap, yielding a voxel size of 
3.3 × 3.3 × 3.25 mm3.
explains pervasive developmental disorders (Ozonoff et al., 1991; 
Happe, 1994; Happe et al., 1996), schizophrenia (Pilowsky et al., 
2000) and reduced social interactions in depression (Uekermann 
et al., 2008). Lower social function is associated with higher risks for 
symptom recurrence 1 year after recovering from a major depressive 
episode (Uekermann et al., 2008). The interest in mirror neurons 
(Rizzolatti and Fabbri-Destro, 2008) provides a potential neural 
basis for intent prediction of others. Imaging studies using single 
photon emission computed tomography (SPECT) (Vogeley et al., 
2001b), positron emission tomography (PET) (Happe et al., 1996) 
or fMRI (Gallagher et al., 2000) have utilized different ToM para-
digms (Stuss et al., 2001; Vogeley et al., 2001a) with mixed results. 
These studies do, however, shed light upon functional networks 
correlated with mentalization and the social nature of the self and 
point to the amygdala, the superior temporal gyrus, and medial and 
orbito-frontal cortex as keys to this high-order mental process.
A “Reading the Mind in the Eyes test” (RMET) (Baron-Cohen 
et al., 2001) was developed to study emotional mental attribu-
tion. This task requires the subject to infer the mental state of an 
individual from the expression in their eyes and immediately sur-
rounding areas, a measure of imagined involvement as opposed to 
an appraisal task. Brain regions previously shown to be significantly 
activated by the task include fronto-temporal neocortical regions, 
such as left dorsolateral prefrontal cortex, medial frontal cortex and 
superior temporal gyrus as well as non-cortical regions such as left 
amygdala, left hippocampus, bilateral insula and left striatum, with 
some of the brain changes being culture specific (Johnston et al., 
2005; Baron-Cohen et al., 2006; Williams et al., 2008).
To date, no studies have investigated the functional neuroanat-
omy of mentalization in depression nor the effects of oxytocin in 
modulating brain activity in depressed individuals. Accordingly, we 
used the RMET task and an intra-nasal oxytocin challenge to inves-
tigate mentalization in unmedicated depressed patients and healthy 
controls. We hypothesized that depressed patients may show greater 
limbic activity during the mentalization task compared to matched 
controls, and that oxytocin will lead to a significant decrease in 
ventro-limbic activity when compared to placebo.
MaterIalS and MethodS
deSIgn
This is a randomized double-blind crossover design to investigate 
the acute effects of intra-nasal oxytocin on mentalization in unmed-
icated depressed patients and matched controls. Primary outcome 
measures consisted of functional blood oxygen level dependent MRI 
(BOLD fMRI) scans. Secondary outcome measures were behavioral 
measures (speed of reaction time). This study was approved by the 
Medical University of South Carolina (MUSC) Institutional Review 
Board funded by a grant from the Hope for Depression Research 
Foundation, and collaboratively conducted with the MindBrain 
Consortium at Summa Hospitals, Akron, Ohio.
SubjectS
Subjects  were  recruited  from  the  MUSC  outpatient  psychiat-
ric services, the Mood Disorders Program (MDP) and through 
local advertisement. We screened 15 Healthy and 20 Depressed 
subjects and enrolled 22 adult subjects. All subjects signed writ-
ten informed consent. Depressed patients met criteria for major www.frontiersin.org  October 2010  | Volume 1  | Article 134  |  3
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statistic images were thresholded using clusters determined by Z > 2.3 
and a (corrected) cluster significance threshold of p = 0.05 (Worsley, 
2001) for identification of voxels with statistically significant activa-
tion during three conditions in individual subjects (fixed effect). 
We then performed a group mean (baseline depressed + matched 
controls) and unpaired t-tests between oxytocin and placebo condi-
tions (random effect; FLAME 1 + 2 option).
reSultS
Eight unmedicated depressed subjects (eight females, four African-
Americans, four Caucasians) and nine matched controls (eight 
females, five African-Americans, four Caucasians) completed all 
assessments required for this study. The mean age for depressed sub-
jects was 35.5 years (SD = 10.62), ranging from 26 to 60, and for con-
trols, 36.4 years (SD = 11.40), ranging from 25 to 59. Mean years of 
education post high school were 2.56 (SD = 1.95) for depressed sub-
jects and 4.22 (SD = 1.79) for controls. Co-morbidities of depressed 
subjects included a past history of alcohol dependence (n = 2), social 
phobia (n = 1), obsessive compulsive disorder (n = 1), panic dis-
order without agoraphobia (n = 2), anxiety (n = 1), and anorexia 
nervosa (n = 1). All subjects were right handed. Sixteen subjects 
were employed either part or full time, and one was a homemaker. 
The patient cohort had significant depressive and anxiety symptoms 
compared to healthy controls and tended to show reduced capacity 
for empathy but not? overall emotional intelligence as measured by 
the Mayer–Salovey–Caruso Emotional Intelligence Test (MSCEIT) 
(Mayer et al., 2003) (See Table 1). There was a significant inverse 
correlation  between  subjective  depressive  symptoms  (IDS-SR) 
and empathy quotient (df = 21, r2 = 0.35, p = 0.004).
behavIoral reSultS
Reaction time
Figure 1 shows reaction time slope changes with intra-nasal oxytocin 
in healthy controls and depressed subjects across RMET, gender attri-
bution, and motor cued response. A significant effect was found for 
the slope of the drug × time × group reaction time (RT) interaction 
during RMET [F(1,2551) = 5.99, p = 0.015]. A decreased RT slope 
was found in healthy matched controls [t(2551) = 2.20, p = 0.028] 
relative to an increased slope in depressed subjects [t(2551) = 2.45, 
p = 0.015], suggesting that oxytocin administration was associated 
with faster reaction times in the healthy cohort and slower reaction 
times in the depressed cohort after controlling for placebo and pre-
drug performance. A significant effect was also found for the slope 
of the drug × time × group RT interaction during gender attribu-
tion [F(1,2510) = 14.82, p < 0.0001]. Again, a decreased RT slope 
was found in healthy matched controls [t(2510) = 4.27, p < 0.0001] 
relative to an increased slope in depressed subjects [t(2510) = 3.85, 
p < 0.0001]. Again, this suggests that oxytocin administration was 
associated with faster reaction times in the healthy cohort and slower 
reaction times in the depressed cohort after controlling for placebo 
and pre-drug performance. Lastly, a significant effect was found for 
the slope of the drug × time × group RT interaction during motor 
cued response [F(1,2507) = 6.87, p = 0.009]. Oxytocin administra-
tion was associated with decreased RT slope in healthy matched 
controls [t(2507) = 2.92, p = 0.004] relative to an increased slope 
in depressed subjects [t(2507) = 2.62, p = 0.009] after controlling 
for placebo and pre-treatment performance. The mean effect size 
data analySIS
Demographics and psychological measures
Descriptive statistics were performed using SPSS 16.0 for Macintosh 
(SPSS Inc., Chicago, IL, USA) and included mean, standard devia-
tion, Student’s t-test, Pearson Chi-square test. All tests were two-
tailed at 0.05 significant level and assumed equal variance.
fMRI data processing methods
fMRI image data was first transferred to a workstation where it was 
converted into Analyze format using MRICro1 and then subjected 
to the following pre-statistics processing steps using FMRI FEAT 
(FMRI Expert Analysis Tool) Version 5.92, part of FSL (FMRIB’s 
Software Library2). Each dataset was spatially normalized into an 
high resolution structural scan MNI template with FLIRT (Jenkinson 
and Smith, 2001; Jenkinson et al., 2002) We applied MCFLIRT for 
motion correction (Jenkinson et al., 2002) and reviewed all data-
sets for remaining motion, which was less than 0.5 mm along all 
three major axes (x, y, z) for all subjects. In addition, we applied 
non-brain removal using BET (Smith, 2002); spatial smoothing 
using a Gaussian kernel of FWHM 8.0 mm; grand-mean intensity 
normalization of the entire 4D dataset by a single multiplicative 
factor and highpass temporal filtering (Gaussian-weighted least-
squares straight line fitting, with sigma = 50.0 s).
Behavioral data
Individual responses collected by IFIS during RMET were collated, 
checked for missing responses and collated in an Excel spreadsheet. 
Reaction Time (RT) and Accuracy of Response (AC) were noted. 
Final analysis included mean, standard deviation, Student’s t-test, 
and Pearson Chi-square test. All tests were two-tailed and assumed 
equal variance.
For mixed models examining the effects of drug by time, pre-drug 
administration conditions were coded in the dataset as “0,” post-drug 
were coded as “1,” placebo conditions were coded as “0” and oxytocin 
conditions were coded as “1.” Hierarchical Linear Modeling (HLM) 
was implemented using PROC MIXED in SAS (SAS Institute Inc., 
Cary, NC) to assess the linear effect of the interaction of “time” (pre 
to post-drug administration) and “treatment type” (oxytocin versus 
placebo) on reaction time and accuracy of response between groups 
(thereby by testing a series of 2 × 2 × 2 mixed models). HLM has been 
shown to handle nested models with serially dependent data points 
and randomly distributed missing values appropriately (Raudenbush 
and Chan, 1993; de Leeuw and Kreft, 1995; Hoffman and Gavin, 1998; 
Nezlek and Zyzniewski, 1998). Additionally, this approach is grow-
ing in popularity among clinical and educational researchers due to 
its flexibility and appropriateness for data typically encountered in 
clinical and social science research (Sliwinski and Hall, 1998; Kuo 
et al., 2000; McGuigan et al., 2003). The covariance structure was 
“unstructured” and the estimation method was REML.
fMRI statistical analysis
Time-series statistical analysis was carried out using FILM with local 
autocorrelation correction (Woolrich et al., 2001). Potentially con-
founding motion over time was regressed out. Z (Gaussianized T/F) 
1http://www.sph.sc.edu/comd/rorden/mricro.html
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ard error) for each variable pre to post-oxytocin or placebo. No 
significant antidepressant effects of oxytocin were observed in this 
provocation-paradigm study.
FunctIonal IMagIng
The corresponding brain atlas coordinates and the fMRI activa-
tions for healthy controls and depressed subjects are presented in 
Table 3.
(Cohen’s d) across all RT for oxytocin is small at 0.18. Table 2 shows 
the mean values (and standard error) for each variable pre to post-
oxytocin or placebo.
Accuracy of response
There were no significant changes with accuracy of response (AR) 
across variables or conditions. Table 2 summarizes the findings 
described above and Table 2 shows the mean values (and stand-
Table 1 | Demographics and clinical characteristics of unmedicated depressed subjects and their matched healthy controls. Significant differences 
were found in depressive symptoms (HDRS, IDS-SR, ANPS-Sadness), anxiety symptoms (STAY-I and ANPS-Fear), and capacity to care (ANPS-Care). Note that 
a trend for differences on Empathy Quotient and ANPS-Spirituality.
  Depressed  Controls  Significance
Age  M = 35.5, SD = 10.62  M = 36.4, SD = 11.40  0.86
Sex  8 Female  8 Female, 1 male 
Race  4 African-American, 4 White  5 African-American, 4 White 
Marital status  5 Single, 2 married, 1 separated  3 Single, 4 married, 2 separated 
Education (years post high school)  M = 2.56, SD = 1.95  M = 4.22, SD = 1.79  0.087
Employment  8 Full time, 1 part time  4 Full time, 3 part time, 1 homemaker 
HRSD  M = 21.38, SD = 5.15  M = 1.4, SD = 1.42  0.000
IDS-SR 30 items  M = 32.75, SD = 11.25  M = 3.78, SD = 3.53  0.000
STAI Y-2  M = 55.75, SD = 7 .92  M = 26.88, SD = 3.72  0.000
ANPS-seeking  M = 21.38, SD = 4.00  M = 23.89, SD = 3.02  0.161
ANPS-fear  M = 21.88, SD = 1.13  M = 19.44, SD = 1.67  0.003
ANPS-care  M = 23.38, SD = 1.77  M = 18.22, SD = 2.64  0.000
ANPS-anger  M = 20.75, SD = 1.83  M = 19.22, SD = 3.53  0.290
ANPS-play  M = 20.38, SD = 2.67  M = 22.00, SD = 2.40  0.206
ANPS-sadness  M = 23.63, SD = 2.50  M = 17 .67 , SD = 2.45  0.000
ANPS-spirituality  M = 18.75, SD = 1.58  M = 16.33, SD = 2.96  0.057
MSCEIT total  M = 96.08, SD = 21.31  M = 101.26, SD = 15.45  0.596
Empathy quotient  M = 40.00, SD = 12.44  M = 49.67 , SD = 8.09  0.074
Table 2 | Reaction times (RT) in milliseconds and accuracy of response (AC) in unmedicated depressed subjects and their matched healthy controls 
during fMRI sessions. Data represent mean and standard deviation across three variables (RMET, gender attribution, and cued-motor response) and four 
conditions (pre-oxytocin, post-oxytocin, pre-placebo, and post-placebo).
  Pre-placebo  Pre-oxytocin  Post-placebo  Post-oxytocin
RT RMET
  Matched controls  4396.3 ± 1499.8  4198.5 ± 1728.6  4092.5 ± 1560.8  4222.8 ± 1293
  Depressed  3945.1 ± 1260.7  4201.6 ± 1169.3  3878.5 ± 1328.3  4119.8 ± 1297 .2
RT gender attribution
  Matched controls  2168.7 ± 958.3  2126.1 ± 853.3  2023.2 ± 950.7  1936.4 ± 710.3
  Depressed  1673.7 ± 651.6  1787 .4 ± 717 .6  1648.3 ± 774.5  1771.3 ± 880.8
RT motor cued response
  Matched controls  1416.8 ± 592  1464.4 ± 730.2  1363.1 ± 791.9  1351.7 ± 465.6
  Depressed  1214.7 ± 472.9  1257 .6 ± 505  1134.6 ± 461.8  1240.5 ± 395.9
AC RMET
  Matched controls  60.6%  59.4%  64.2%  67 .9%
  Depressed  65.8%  67%  67%  70.6%
AC gender attribution
  Matched controls  89.4%  82.8%  87 .8%  90%
  Depressed  87 .2%  88.1%  83.8%  86.9%
AC motor cued response
  Matched controls  98.1%  94.1%  93.1%  97 .8%
  Depressed  96.9%  97 .5%  95.6%  97 .2%www.frontiersin.org  October 2010  | Volume 1  | Article 134  |  5
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Table 3 | fMRI activations Talairach coordinates and corresponding z-scores.
z-Score  x  y  z  Left/right  Region  Brodmann area
BASeLIne gRouPS AnALySIS
Healthy controls n = 9
RMET group mean
5.7  −46  14  26  Left  Middle frontal gyrus  Brodmann area 9
5.57  22  −64  54  Right  Superior parietal lobule  Brodmann area 7
5.51  −6  6  60  Left  Superior frontal gyrus  Brodmann area 6
5.4  32  −62  52  Right  Superior parietal lobule  Brodmann area 7
5.19  −20  −64  58  Left  Superior parietal lobule  Brodmann area 7
4.87  −32  −84  −10  Left  Inferior occipital gyrus  Brodmann area 18
RMET minus gender group mean
4.5  −10  26  56  Left  Superior frontal gyrus  Brodmann area 6
4.39  −10  12  6  Left  Caudate  Caudate Body
4.32  −6  54  40  Left  Medial frontal gyrus  Brodmann area 9
3.99  −12  50  28  Left  Superior frontal gyrus  Brodmann area 9
3.91  −10  58  22  Left  Superior frontal gyrus  Brodmann area 10
3.85  56  −40  −4  Right  Middle temporal gyrus  Brodmann area 21
5.79  −46  26  −10  Left  Inferior frontal gyrus  Brodmann area 47
5.21  −54  22  8  Left  Inferior frontal gyrus  Brodmann area 45
4.52  −52  −48  2  Left  Middle temporal gyrus  Brodmann area 22
3.79  −42  10  −36  Left  Middle temporal gyrus  Brodmann area 21
unmedicated depressed n = 8
RMET group mean
5.29  10  18  40  Right  Cingulate gyrus  Brodmann area 32
4.83  36  22  0  Right  Insula  Brodmann area 13
4.66  −22  −58  44  Left  Superior parietal lobule  Brodmann area 7
4.55  30  −4  50  Right  Middle frontal gyrus  Brodmann area 6
4.35  −10  8  2  Left  Caudate  Caudate Head
RMET minus gender group mean
4.3  −58  22  4  Left  Inferior frontal gyrus  Brodmann area 45
4.14  −48  14  −161  Left  Superior temporal gyrus  Brodmann area 38
4.11  −40  28  −10  Left  Inferior frontal gyrus  Brodmann area 47
4.04  −10  14  −6  Left  Caudate  Caudate head
2.3  −14  10  −22  Left  Anterior cingulate gyrus  Brodmann area 25
DIReCT CoMPARISonS BeTween InTRA-nASAL oxyToCIn AnD PLACeBo
Healthy matched controls n = 9
RMET healthy oxytocin > placebo t-test
3.93  −6  6  −8  Left  Caudate  Caudate head
3.82  12  −4  −20  Right  Parahippocampal gyrus  Brodmann area 34
2.66  14  −2  −22  Right  Amygdala 
3.73  28  32  −18  Right  Inferior frontal gyrus  Brodmann area 47
3.72  −8  0  −6  Left  Lentiform nucleus  *
3.67  −10  32  −6  Left  Anterior cingulate  Brodmann area 24
3.67  30  −24  −24  Right  Parahippocampal gyrus  Brodmann area 35
4.24  −40  −30  −10  Left  Caudate  Caudate tail
3.94  −50  8  −18  Left  Superior temporal gyrus  Brodmann area 38
3.7  −56  −8  −6  Left  Superior temporal gyrus  Brodmann area 22
2.7  −4  18  −12  Left  Anterior cingulate gyrus  Brodmann area 25
2.69  −4  48  −14  Left  Anterior cingulate gyrus  Brodmann area 32
Gender healthy oxytocin > placebo t-test
No significant differences
Motor healthy oxytocin > placebo t-test
3.99  50  −27  10  Right  Superior temporal gyrus  Brodmann area 41
3.76  16  −30  11    Right cerebellum 
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Oxytocin versus placebo
Depressed group. During RMET, there was significant activation 
with oxytocin compared to placebo in bilateral superior tempo-
ral gyrus (BA38, 41, and 22), right insula, right precentral gyrus 
(BA44), bilateral cingulate gyri (BA32), left anterior cingulum 
(BA24), left supramarginal gyrus (BA40), right inferior frontal gyrus 
(BA47), right superior and middle frontal gyri (BA8, 9, and 10) (see 
Figure 3). On motor cues, oxytocin led to significant increases in 
bilateral superior and medial frontal gyri (BA6, 8 and 9). Gender 
identifications and RMET minus gender identifications did not 
differ between oxytocin and placebo conditions.
Matched healthy controls. During RMET, there was significant acti-
vation with oxytocin compared to placebo in right parahippocampal 
gyrus extending to the amygdala, inferior frontal gyrus (BA47), left 
head and tail of the caudate and superior temporal gyrus (BA22 
Baseline mean groups
During the RMET task, at baseline and prior to inhaling study 
drug, depressed and normal control subjects showed statistically 
significant activations of the visual cortex, associated visual areas, 
the fusiform gyrus, and various limbic areas, along with the anterior 
cingulate. The depressed group showed significant activation in the 
right anterior cingulate gyrus (BA32), insula and middle frontal 
gyrus (BA6), left superior parietal lobe (BA7) and head of the cau-
date. The two groups were not significantly different in intensities 
or areas of activation on the mentalization task. They did however 
differ when contrasting RMET minus gender identification (see 
Figure 2). The depressed group showed predominantly ventral acti-
vations with left inferior frontal gyrus, superior temporal gyrus, 
subgenual cingulum and head of the caudate. The healthy controls 
showed activations in the superior and middle frontal gyri, the 
orbito-frontal cortex and middle temporal gyrus (BA21, 22).
3.72  60  −21  9  Right  Superior temporal gyrus  Brodmann area 42
3.65  47  −31  15  Right  Superior temporal gyrus  Brodmann area 41
3.62  51  −23  10  Right  Transverse temporal gyrus  Brodmann area 41
3.62  51  −30  15  Right  Superior temporal gyrus  Brodmann area 41
Depressed unmedicated n = 8
RMET depressed oxytocin > placebo t-test
3.99  58  10  −20  Right  Superior temporal gyrus  Brodmann area 38
3.79  54  8  2  Right  Insula  Brodmann area 13
3.77  56  12  6  Right  Precentral gyrus  Brodmann area 44
3.73  50  18  −14  Right  Inferior frontal gyrus  Brodmann area 47
3.71  58  8  −10  Right  Superior temporal gyrus  Brodmann area 22
3.76  −4  36  16  Left  Anterior cingulate  Brodmann area 24
3.75  6  34  26  Right  Cingulate gyrus  Brodmann area 32
3.72  −4  36  20  Left  Anterior cingulate  Brodmann area 32
3.7  6  38  30  Right  Medial frontal gyrus  Brodmann area 6
3.73  −56  −30  10  Left  Superior temporal gyrus  Brodmann area 41
3.73  −64  −52  24  Left  Superior temporal gyrus  Brodmann area 22
3.69  −58  −48  32  Left  Supramarginal gyrus  Brodmann area 40
3.65  −52  −32  8  Left  Superior temporal gyrus  Brodmann area 22
3.54  30  58  −6  Right  Superior frontal gyrus  Brodmann area 10
3.52  44  36  28  Right  Middle frontal gyrus  Brodmann area 9
3.41  28  44  34  Right  Middle frontal gyrus  Brodmann area 8
3.35  34  52  12  Right  Middle frontal gyrus  Brodmann area 10
3.33  24  48  22  Right  Superior frontal gyrus  Brodmann area 9
RMET minus gender depressed oxytocin > placebo t-test
No significant differences
Gender depressed oxytocin > placebo t-test
No significant differences
Motor depressed oxytocin > placebo t-test
3.51  0  58  28  Left  Medial frontal gyrus  Brodmann area 9
3.41  −18  56  30  Left  Superior frontal gyrus  Brodmann area 9
3.39  4  60  34  Right  Medial frontal gyrus  Brodmann area 8
3.44  −2  58  38  Left  Medial frontal gyrus  Brodmann area 8
3.47  2  56  32  Left  Medial frontal gyrus  Brodmann area 6
3.59  −2  34  54  Left  Superior frontal gyrus  Brodmann area 6
3.6  8  6  56  Right  Medial frontal gyrus  Brodmann area 6
Table 3 | (Continued)
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thize. Along with activating attentional and visual networks, RMET 
also involved anterior ventromedial regions. Oxytocin differen-
tially affected normal and depressed cohorts. In controls, oxytocin 
enhanced activation of ventromedial, amygdala, parahippocampal 
and semantic associative areas. Depressed   subjects showed increases 
in higher order cognitive areas and insula. Oxytocin also showed 
opposite effects in reaction times with increased speed of response 
in healthy controls and a slowing among the depressed.
MentalIzIng In depreSSIon
The mentalization task is a novel paradigm in this population. It 
is relatively complex and recruits several complementary limbic, 
attention and high-level executive networks. Pathological states 
and 38) (see Figure 4). On Motor Cues, oxytocin led to significant 
increases in right superior temporal gyrus (BA41 and 42) and right 
cerebellum. Gender identifications and RMET minus gender identi-
fications did not differ between oxytocin and placebo conditions.
dIScuSSIon
To our knowledge, this is the first study investigating intra-nasal 
oxytocin in unmedicated depressed and matched controls using 
fMRI. We employed RMET, a visual perceptual task that involves 
more affectively valenced decision making and mental attributions 
of other people. The task emphasizes affective “involvement” rather 
than cognitive “appraisal.” At baseline, the two groups were signifi-
cantly different in their distress symptoms and capacity to empa-
FIguRe 1 | Reaction time slope changes with intra-nasal oxytocin in healthy matched controls (blue) and depressed subjects (red) across RMeT, gender 
attribution and motor cued response.
FIguRe 2 | Baseline RMeT minus gender Attribution: Predominant ventral activations in unmedicated depressed subjects at baseline (red) compared to 
superior frontal and temporal activations in healthy matched controls (blue).Frontiers in Psychiatry  |  Neuropsychiatric Imaging and Stimulation    October 2010  | Volume 1  | Article 134  |  8
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FIguRe 3 | Baseline (green) and added activations with oxytocin compared to placebo (red) in unmedicated depressed subjects during RMeT.
FIguRe 4 | Baseline (green) and added activations with oxytocin compared to placebo (red) in healthy matched controls during RMeT.
such as depression degrade mentalization (Uekermann et al., 2008), 
perhaps by limiting emotional involvement with all things and 
people in their experiential world and reflection upon their internal 
world, functioning more in a purely cognitively appraised, distant 
or disconnected fashion. The results reported here suggest that 
depression may represent a homeostatic alteration in contributions 
of these systems to executing this task compared to healthy controls. 
Many of the findings we report are in line with abundant existing 
evidence of limbic and executive dysfunction in depression (Green 
et al., 2007; Northoff, 2007). The distinct increase in ventro-limbic 
activity is also reminiscent of mood induction studies (George et al., 
1995; Mayberg et al., 1999). But the direct consequences of such 
dysregulation in not clear since behavioral performance on RMET 
in depressed patients was not significantly different from controls www.frontiersin.org  October 2010  | Volume 1  | Article 134  |  9
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and did not appear biased towards negative affect. The task itself 
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Although we did not see any significant difference between groups 
with RMET contrast, we did find higher anterior subgenual cingulate 
activation and anterior temporal pole during RMET minus gender 
attribution in depressed, suggesting that mentalization preferentially 
linked processing of perceptual inputs to internal visceral emotional 
experiences (Figure 2). This contrasts with activations of anterior 
frontal pole, supramotor and working memory areas in healthy con-
trols. Note that both groups exhibited activations of semantic and 
word processing regions but there too, activity was more restricted 
to the inferior frontal gyrus in depressed patients. These finding, 
along with a relatively faster reaction times in depressed patients, 
suggests that this cohort mentalized in a more primary, impulsive 
way, whereas in healthy controls the task engaged a more distributed 
network that involved higher order abstract cognitive and emotional 
integrative regions (Petrides and Pandya, 2007).
the eFFectS oF oxytocIn on MentalIzatIon
Our fMRI data reveals that intra-nasal oxytocin has a differen-
tial effect upon the brain of depressed and normal people, as if 
in the state of depression, oxytocin “recruits” a more emotionally 
reflexive appraisal state that is less affectively reflective. Oxytocin 
increased primarily emotional circuits as in the cingulate (BA24) 
and insula in depressed patients during RMET. These increases 
appear to be in the same general directions as baseline activation 
patterns (Figure 3). Conversely, oxytocin increased ventral activ-
ity in healthy controls adding a different and substantial “primary 
affective appraisal” regional component (amygdala, parahippoc-
ampus) along with social appraisal (BA25 and 32) to baseline 
activation pattern (Figure 4). This is in contrast with reports of 
reduced activation of the amygdala in response to fear-inducing 
visual stimuli coupled with oxytocin inhalation (Kirsch et al., 2005). 
Oxytocin also moderately decreased the reaction time in healthy 
controls. This is in line with reports of oxytocin improving RMET 
in healthy individuals when analyses focused on the more complex 
and difficult items (Domes et al., 2007), In contrasts, depressed 
patients remained faster at their responses than controls but tended 
to show a more deliberative response to the situations. Oxytocin 
did not alter the accuracy of responses in either group.
lIMItatIonS
Number of subjects is relatively small although the total scans ana-
lyzed is 80. Individual variability and total sample size cannot iden-
tify main responders. The exclusion of one male subject in healthy 
controls did not significantly change the results. The effect size on 
behavioral response (RT) is small and perhaps due to relatively small 
single dose of oxytocin and the intra-nasal route. Added to this are 
the small size of the olfactory nasal mucosa, the small instillation 
volume and the relatively fast turnover of cerebrospinal fluid which 
will render the total amount of active oxytocin that reached the 
brain small (Pontiroli, 1998; Petrides and Pandya, 2007). Oxytocin 
is also known to gradually degrade into several metabolites that may 
reduce the potency of the preparation (Claybaugh and Uyehara, 
1993; Burbach et al., 1998). The effect size on RT may have been 
influenced by the relative simple to moderate difficulty in the RMET 
images themselves which may limited the range of improvement 
after oxytocin inhalation (Domes et al., 2007).
In summary, we have shown that depressed subjects perform a 
mental attribution task differently than healthy matched controls. 
In addition, a single dose of intra-nasal oxytocin has distinct effects 
on functional activity of networks involved in a mental attribution 
task and enhances cognitive and emotional appraisal. These effects 
appear to be dependent on the distress levels of individuals, their 
likely capacity to empathize and the underlying homeostasis of the 
affective primary brain processes. It is not clear from our study what 
role, if any, oxytocin may have in modulating and perhaps treating 
depressive symptoms. Other studies of this important component 
of depressive pathology are needed with likely longer exposure and 
repeated oxytocin administration.
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